Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iVIZIA
- Development stage
- Unknown
- Lead developer
- Théa Pharmaceuticals
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
iVIZIA is a line of over-the-counter (OTC) ophthalmic products developed by Théa Pharma for the management of dry eye disease and eyelid hygiene. The flagship product, iVIZIA Sterile Lubricant Eye Drops, is a preservative-free formulation containing povidone (0.5%) as the active ingredient, along with hyaluronic acid and trehalose. This combination is designed to provide extended relief by stabilizing the tear film, rehydrating the ocular surface, and providing bioprotection against desiccation. Hyaluronic acid, a natural component of the tear film, enhances water retention by binding up to 1,000 times its weight in water, while trehalose acts as an osmoprotectant and bioprotectant for corneal epithelial cells. The product is marketed for patients with various types of dry eye, including those who wear contact lenses, and is based on the formulation of the European product Thealoz Duo.
- Brand names
- iVIZIA
- Other names
- iVIZIA Sterile Lubricant Eye DropsiVIZIA Lubricating Eye Gel
Beyond the preview
Go deeper on iVIZIA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iVIZIA.